<DOC>
	<DOCNO>NCT00439101</DOCNO>
	<brief_summary>The purpose research study determine megestrol acetate use appetite stimulant improve weight gain child cancer poor nutrition . The study design randomize , double blind , placebo control trial . Secondarily , would like determine effect improvement weight body composition DEXA scan . This include whether drug result increase fat , fat-free mass , . If patient gain weight would like know improves quality life . Finally , many child cancer lose much weight require feed occur tube put nose stomach ( NG feed ) . The tube painful put uncomfortable . Some child may also require nutrition give vein ( Total Parenteral Nutrition TPN ) . We try see prevent procedure happen subject gain weight . This study tell doctor drug truly work ( work ) child underweight .</brief_summary>
	<brief_title>A Randomized Clinical Trial Megestrol Acetate Appetite Stimulant Malnourished Children With Cancer</brief_title>
	<detailed_description>Overview study phase Prior randomization phase , draw blood work ( 1 teaspoon ) regular blood work see you/your child meet final eligibility requirement . If result within normal limit , proceed Randomization Phase . If result within normal limit your/your child 's age , you/your child able proceed study pas test result regular oncologist . Randomization Phase If you/your child agree take part study you/your child equal chance receive one two possible liquid : Megace ( 7.5 mg/kg/day take morning ) amount placebo ( placebo substance look taste exactly like real medicine , however inactive substance contains drug ) . This assign drug placebo call randomization . Neither physician choose know treatment receiving . This `` blinding '' necessary fairly test drug . In emergency , physician immediately find drugs/treatments receive . Once randomize , you/your child give supply drug placebo . Both drug placebo lemon-lime flavored liquid . There pills tablet take . You/your child take liquid mouth amount prescribe per day . You take liquid every day 90 day ( 3 month ) . The liquid take half an-hour breakfast . Pre-treatment Information Collection Phase Before you/your child start take liquid , collect initial information . This include take your/your child 's weight height . A dietitian perform assessment you/your child 's body composition use tool call caliper . This briefly pinch skin back your/your child 's arm . It hurt . The dietitian also measure your/your child 's upper arm use tape measure . A research nurse ask series question call Quality Life assessment . This tell u you/your child feel start study . Afterwards , you/your child scan call DEXA ( stand Dual Energy X-Ray Absorptiometry ) scan do assess your/your child 's body composition . A DEXA scan hurt require you/your child lie still table scanner move you/your child . Like scan , radiation exposure . However , total amount radiation small ( half radiation exposure normal chest xray ) . This cause problem you/your child . We also draw additional blood ( approximately 1 teaspoon ) central line . You/your child extra poke purpose study . Follow-up Phase You/your child follow closely team doctor dieticians 90 day you/your child study . Follow-up occur normally schedule see doctor . This occur either Pediatric Oncology outpatient clinic admit BC Children 's Hospital ( Vancouver ) Stollery Children 's Hospital ( Edmonton ) . You make special appointment purpose study . We watch weight closely 3 month study . If you/your child lose additional 15 % your/your child 's baseline ( start ) weight stop take medication placebo . You receive regular medical care . This may include start tube feed TPN . We also take additional blood work least every 2 week 3 month . This do your/your child 's central line time regular blood work drawn . Once month research nurse contact phone see thing go ask question possible side effect . Study Conclusion Phase At end study collect information Pre-treatment Information Collection Phase . This include your/your child 's weight , height , caliper arm measurement well ask quality life question . You second DEXA scan do . After 90 day tell whether receive drug ( Megace ) inactive substance ( Placebo ) . The time commitment you/your child take part research minimal . Each DEXA scan ( you/your child ask complete 2 DEXA scan study ) take approximately 1 hour . Each study nurse interview ( 3 ) take approximately 10-15 minute time . The quality life question ask three time take approximately 5-10 minute time complete .</detailed_description>
	<mesh_term>Malnutrition</mesh_term>
	<mesh_term>Central Nervous System Stimulants</mesh_term>
	<mesh_term>Megestrol Acetate</mesh_term>
	<mesh_term>Megestrol</mesh_term>
	<mesh_term>Appetite Stimulants</mesh_term>
	<criteria>1 . Any subject malnourishment presume secondary cancer cancer relate therapy eligible . Malnourishment define one follow time enrollment study : A documented weight loss â‰¥ 5 % attributable acute fluid loss . A weight deficit &lt; 90 % expect height , age gender attributable acute fluid loss . A mid upperarm circumference &lt; 5th percentile age gender . 2 . Subjects malignancy ( except cover exclusion criterion ) either diagnosis active therapy . 3 . Subjects relapse disease eligible study . 4 . Subjects palliative therapy eligible study provide predicted life expectancy least 3 month . 5 . Subjects must &lt; 18 year time admission study . 6 . Subjects receive corticosteroid study eligible provide require &gt; 7 day 6week period . The begin 6week period define day first dose corticosteroid take . 7 . Subjects receive &gt; 7 day corticosteroids previous 6weeks enter study eligible provide received corticosteroid precede 14 day . 8 . Signed informed consent must obtain accord institutional guideline enrollment study . 1 . Any child receive nutritional intervention include supplemental enteral ( nasogastric / nasojejunal / gastrostomy ) parenteral ( TPN ) nutrition . 2 . Subjects expect receive corticosteroid &gt; 7 day 6week period . The 6week period define start first day steroid take . 3 . Subjects previous 6weeks receive &gt; 7 day corticosteroid AND least 14 day last dose corticosteroid . 4 . Subjects concurrently prescribe appetitestimulating medication . 5 . Subjects hormonesensitive tumor include meningioma . 6 . Subjects follow condition : Adrenal insufficiency Defined : A prestudy 8:00 AM serum cortisol lower define limit study ( see section 7.4 ) plus confirmation adrenal insufficiency ACTH stimulation test . Diabetes Mellitus Defined : A prestudy random chemstrip venous blood glucose &gt; 10 mmol/L confirmation fast blood glucose next morning great normal limit define study Pregnancy Subjects acute illness deem clinically significant study coordinator ( e.g. , sepsis , congestive heart failure , hypertensive crisis , intensive care unit , acute chronic renal failure , acute chronic hepatic failure ) . Subjects previous current thromboembolic condition ( exclude central venous thrombosis relate placement central venous catheter ) . 7 . Subjects predict life expectancy le 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>weight loss</keyword>
	<keyword>malignancy</keyword>
	<keyword>corticosteroid</keyword>
	<keyword>supplemental feeding</keyword>
	<keyword>adrenal insufficiency</keyword>
	<keyword>diabetes</keyword>
</DOC>